A case of ocular benign lymphoid hyperplasia treated with bevacizumab injection.

A Case of Ocular Benign Lymphoid Hyperplasia Treated with Bevacizumab Injection
Citations

SCOPUS

6

초록

We report the first case of ocular benign lymphoid hyperplasia (BLH) treated with subconjunctival injection of bevacizumab (Avastin). A 27-year-old man presented to our clinic with conjunctival masses and limbal neovascularization. An incisional biopsy yielded the diagnosis of BLH. The patient was subsequently given a subconjunctival injection of bevacizumab (1.25 mg / 0.1 mL). The patient did not experience recurrence or malignant metaplasia during the one-year follow-up period. In patients with conjunctival BLH, subconjunctival injection of bevacizumab can be a useful treatment option in patients unable to undergo a surgical procedure due to limbal neovascularization.

키워드

Bevacizumab; Conjunctival benign lymphoid hyperplasia; Subconjunctival injection; angiogenesis inhibitor; bevacizumab; monoclonal antibody; adult; article; case report; conjunctiva; conjunctiva disease; cornea limbus; human; hyperplasia; intraocular drug administration; lymphoid tissue; lymphoproliferative disease; male; neovascularization (pathology); pathology; vascularization; Adult; Angiogenesis Inhibitors; Antibodies, Monoclonal; Conjunctiva; Conjunctival Diseases; Humans; Hyperplasia; Injections, Intraocular; Limbus Corneae; Lymphoid Tissue; Lymphoproliferative Disorders; Male; Neovascularization, Pathologic
제목
A case of ocular benign lymphoid hyperplasia treated with bevacizumab injection.
제목 (타언어)
A Case of Ocular Benign Lymphoid Hyperplasia Treated with Bevacizumab Injection
저자
Oh, Doo Hwan; Chun, Yeoun Sook; Kim, Jae Chan
DOI
10.3341/kjo.2011.25.1.57
발행일
2011-02
유형
Article
저널명
Korean Journal of Ophthalmology
권
25
호
1
페이지
57 ~ 59